HomeCompareALBBY vs MO

ALBBY vs MO: Dividend Comparison 2026

ALBBY yields 19.90% · MO yields 6.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MO wins by $7.5K in total portfolio value· pulled ahead in Year 10
10 years
ALBBY
ALBBY
● Live price
19.90%
Share price
$10.05
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$72.6K
Annual income
$6,667.68
Full ALBBY calculator →
MO
Altria Group Inc.
● Live price
6.36%
Share price
$65.99
Annual div
$4.20
5Y div CAGR
22.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$80.1K
Annual income
$30,159.17
Full MO calculator →

Portfolio growth — ALBBY vs MO

📍 MO pulled ahead of the other in Year 10

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodALBBYMO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ALBBY + MO cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ALBBY pays
MO pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ALBBY
Annual income on $10K today (after 15% tax)
$1,691.54/yr
After 10yr DRIP, annual income (after tax)
$5,667.53/yr
MO
Annual income on $10K today (after 15% tax)
$540.99/yr
After 10yr DRIP, annual income (after tax)
$25,635.29/yr
At 15% tax rate, MO beats the other by $19,967.77/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ALBBY + MO for your $10,000?

ALBBY: 50%MO: 50%
100% MO50/50100% ALBBY
Portfolio after 10yr
$76.3K
Annual income
$18,413.42/yr
Blended yield
24.12%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MO right now

ALBBY
No analyst data
Altman Z
7.1
Piotroski
5/9
MO
Analyst Ratings
16
Buy
9
Hold
1
Sell
Consensus: Buy
Price Target
$61.25
-7.2% upside vs current
Range: $47.00 — $68.00
Altman Z
3.2
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ALBBY buys
0
MO buys
0
No recent congressional trades found for ALBBY or MO in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricALBBYMO
Forward yield19.90%6.36%
Annual dividend / share$2.00$4.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%22.6%
Portfolio after 10y$72.6K$80.1K
Annual income after 10y$6,667.68$30,159.17
Total dividends collected$41.2K$74.5K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: ALBBY vs MO ($10,000, DRIP)

YearALBBY PortfolioALBBY Income/yrMO PortfolioMO Income/yrGap
1$12,690$1,990.05$10,570$780.30+$2.1KALBBY
2$15,939$2,360.17$11,381$1,032.90+$4.6KALBBY
3$19,825$2,770.41$12,535$1,392.73+$7.3KALBBY
4$24,433$3,220.46$14,193$1,920.91+$10.2KALBBY
5$29,853$3,709.39$16,618$2,723.68+$13.2KALBBY
6$36,178$4,235.71$20,263$3,993.80+$15.9KALBBY
7$43,508$4,797.38$25,936$6,098.36+$17.6KALBBY
8$51,945$5,391.92$35,166$9,775.01+$16.8KALBBY
9$61,598$6,016.43$51,026$16,597.78+$10.6KALBBY
10← crossover$72,577$6,667.68$80,113$30,159.17$7.5KMO

ALBBY vs MO: Complete Analysis 2026

ALBBYStock

Alibaba Health Information Technology Limited, an investment holding company, engages in the pharmaceutical direct sales, pharmaceutical e-commerce platform, and healthcare and digital services businesses in Mainland China and Hong Kong. It offers range of prescription drugs, over-the-counter drugs, nutritional supplements, medical devices, contact lenses, and various other health-related products through its online stores on Tmall.com and offline pharmacy outlets to business-to-customer and business-to-business customers; and pharmaceutical products, medical devices and healthcare products, health food, sexual health and family planning products, contact lenses, and medical and healthcare services through its e-commerce platform. The company also provides medical and healthcare services, including medical checkups, nucleic acid testing, medical consultation, registration, vaccination, and TCM through various channels, such as Taobao, Tmall, Alipay, Dr. Deer APP, Gaode, DingTalk, and Quark. In addition, it engages in the tracking business; provision of network hospital, healthcare related internet information, internet information, and healthcare related technical services; operation of internet hospitals; and asset management services. The company was formerly known as CITIC 21CN Company Limited and changed its name to Alibaba Health Information Technology Limited in September 2014. Alibaba Health Information Technology Limited is based in Causeway Bay, Hong Kong.

Full ALBBY Calculator →

MOConsumer Staples

Altria Group, Inc., through its subsidiaries, manufactures and sells smokeable and oral tobacco products in the United States. The company provides cigarettes primarily under the Marlboro brand; cigars and pipe tobacco principally under the Black & Mild brand; and moist smokeless tobacco products under the Copenhagen, Skoal, Red Seal, and Husky brands, as well as provides on! oral nicotine pouches. It sells its tobacco products primarily to wholesalers, including distributors; and large retail organizations, such as chain stores. Altria Group, Inc. was founded in 1822 and is headquartered in Richmond, Virginia.

Full MO Calculator →
📬

Get this ALBBY vs MO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ALBBY vs SCHDALBBY vs JEPIALBBY vs OALBBY vs KOALBBY vs MAINALBBY vs PMALBBY vs BTIALBBY vs PG

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.